Study summary · research use only
[EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION]
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
In this study, the authors assessed cellular and metabolic geroprophylactic effects of the synthetic tripeptides vesugen and pinealon for correcting biological age. 32 people (18 men, 12 women) aged 41-83 years with polymorbidity and organic brain syndrome in remission participated. The abstract reports that Pinealon and Vesugen had a significant anabolic effect and improved central nervous system and organ activity, slowing the rate of aging by biological-age indicators, with Vesugen showing a more visible effect. It also notes prooxidant activity by chemiluminescence and a decrease in CD34+ hematopoietic cells indicating inhibited hemopoiesis, and that the peptides did not affect chromatin condensation. The authors describe the peptides as geroprotectors of an anabolic neuroprotective, non-antioxidant type.
Abstract
We've estimated the cellular and metabolic part of geroprophylactic effects of short synthetic tripeptides vesugen and pinealon for correction of the biological age. 32 people (18 men, 12 women) aged 41-83 years with polymorbidity and the organic brain syndrome in remission participated in the study. The preparations of "Pinealon" and "Vesugen" have had the significant anabolic effect. They have improved the activity of the Central nervous system and other vital organs, which slows the rate of aging by biological age indicators. Vesugen has demonstrated more visible geroprophylactic effect than Pinealon. At the same time we've found the prooxidant activity through chemiluminescence. Decrease of markers CD34+ positive hematopoietic polypotent cells in blood has shown significant inhibition of hemopoiesis. Apparently, the cells have not been involved in the adaptive reactions. Pinealon and Vesugen haven't affected the degree of chromatin condensation, so they are safe on nuclear genetic level. This property should be studied in future. In geriatric practice, we recommend to apply the peptides Pinealon and Vesugen as geroprotectors anabolic neuroprotective and no antioxidant type for reducing the rate of aging in patients with the organic brain syndrome vascular and/or traumatic genesis.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.